Vancomycin-induced severe thrombocytopenia in a young infant
Rev. Soc. Bras. Med. Trop
;
51(6): 873-875, Nov.-Dec. 2018. tab, graf
Artículo
en Inglés
| LILACS
| ID: biblio-977108
ABSTRACT
Abstract Vancomycin is a first-line drug for treating methicillin-resistant Staphylococcus aureus. Thrombocytopenia is a rare adverse reaction to vancomycin treatment, and there are no reports of vancomycin-induced thrombocytopenia (VIT) in infants. We describe the case of a 3-month-old girl who was diagnosed with purulent meningitis. After 13 days of treatment with vancomycin, her platelet count reduced to 8 × 109/L. Vancomycin was discontinued, and intravenous methylprednisolone was administered. The platelet count returned to normal after 4 days. Patients, especially young children, receiving vancomycin for a long clinical course should undergo careful monitoring of laboratory indicators and blood tests.
Texto completo:
Disponible
Índice:
LILACS (Américas)
Asunto principal:
Trombocitopenia
/
Vancomicina
Tipo de estudio:
Estudio diagnóstico
Límite:
Femenino
/
Humanos
/
Lactante
Idioma:
Inglés
Revista:
Rev. Soc. Bras. Med. Trop
Asunto de la revista:
Medicina Tropical
Año:
2018
Tipo del documento:
Artículo
País de afiliación:
China
Institución/País de afiliación:
Xiamen Maternity and Child Care Hospital/CN
Similares
MEDLINE
...
LILACS
LIS